Participants presenting with cryptococcal meningitis while taking ART had similar demographics to those not on ART but had higher baseline CD4 counts and lower baseline fungal burdens in both the AMBITION study and combined dataset (Table 2). This evidence concerns the gene CD4 and Cryptococcal meningitis.